LIM Domain 7 (LMO7) Peptide
-
- Target See all LMO7 products
- LMO7 (LIM Domain 7 (LMO7))
- Origin
- Human, Mouse, Rat, Dog
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunogen (Imm)
- Sequence
- ESTCVSASLP RS
- Characteristics
- The peptide was used in the production of ABIN370135 - Goat Anti-LMO7 / FBXO20 Antibody. It is currently untested in blocking applications.
-
-
- Application Notes
- When peptides are reconstituted in 200ul water, the concentration would be also 0.5mg/ml. To start, the best ratio would be 1:1 (which means molar excess of peptides relative to antibodies when identical volumes are mixed). Please mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. Best is to have two identical blots, to be incubated with equal amount of antibodies, but one with the antibodies pre-adsorbed to the peptide for 20min. Then incubate and develop in parallel the two blots.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
- Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
- Storage
- -20 °C
- Storage Comment
- Shipped at ambient temperature, store at -20°C.
-
- Target
- LMO7 (LIM Domain 7 (LMO7))
- Synonyms
- Gm914 Peptide, C78582 Peptide, FBXO20 Peptide, mKIAA0858 Peptide, lmo7 Peptide, zgc:152922 Peptide, FBX20 Peptide, LOMP Peptide, LIM domain 7 Peptide, LIM domain 7 protein L homeolog Peptide, LIM domain 7 protein Peptide, LIM domain only 7 Peptide, LIM domain 7b Peptide, Lmo7 Peptide, lmo7.L Peptide, lmo7 Peptide, lmo7b Peptide, LMO7 Peptide
-